Molecular Biology Enzymes And Kits & Reagents Market Size, Share,Analysis And Forecast 2018-2025| Grand View Research Inc.
“The global Molecular Biology Enzymes And Kits & Reagents market size was valued at USD 5.77 billion in 2016 and is expected to witness a CAGR of 19.0% during the forecast period.�
Global molecular biology enzymes and kits & reagents market is expected to reach USD 26.7 billion by 2025, according to a new report by Grand View Research, Inc. Expanding pharmaceutical and biotechnology industry in emerging nations is expected to offer significant growth opportunities to the molecular biology enzymes, kits, and reagents market. Furthermore, the increasing adoption of personalized medicine is expected to provide lucrative opportunities to the market. Technological advancements aimed at development of advanced products and increasing R&D investments by leading manufacturers are some of the key factors contributing to increasing demand for these enzymes, kits, and reagents. In addition, increasing adoption of molecular diagnostics is expected to serve this industry as a potential growth driver. Molecular biology enzymes, kits, and reagents are majorly used in genomics-related application areas. Increased funding for research in the field of genomics and sequencing are expected to augment growth during the forecast period. Furthermore, these products are used in the drug discovery and development stages in pharmaceutical and biopharmaceutical companies. Pharmaceutical and biotechnology companies contribute to the largest share of the end users of molecular biology enzymes, kits, and reagents. This dominant share can be attributed to increasing investments in R&D, expanding biopharmaceutical & biotechnology industry in the Asia Pacific region, and government initiatives in various countries to develop the biotechnology & pharmaceutical industry.
Browse Details of Report @ https://www.grandviewresearch.com/industry-analysis/molecular-biology-enzymeskits-reagents-market
Follow Us:
Further key findings from the study suggest:
Kits and reagents held the dominant share of market, by product, as of 2016 owing to their low costs and incessant product launches
Rising number of research activities in molecular biology application areas amongst the end users is one of the key contributing factors responsible for the dominance of this product
The Polymerase Chain Reaction (PCR) segment is expected to witness lucrative growth in the near future owing to the benefits associated with its use in molecular diagnostics
PCR is used in detection and identification of genetic disorders. Rising geriatric population across the globe is also expected to drive this market owing to the use of PCR in detecting and diagnosing geriatric disorders.
Rising demand for personalized medicine fosters the demand for sequencing, which further increases the demand for these enzymes, kits, and reagents
Pharmaceutical and biotechnology companies held a dominant share, by end user in 2016 Rising investments in R&D, expanding pharmaceutical & biotechnology industry, and increasing venture capital investments are some of the major factors contributing to the growth of this segment.
Grand View Research has segmented the molecular biology enzymes and kits & reagents market on the basis of the product, application, end user, and region: Molecular Biology Enzymes, Kits, and Reagents Product Outlook (Revenue, USD Million, 2014 - 2025) Kits and Reagents
Enzymes
Molecular Biology Enzymes, Kits, and Reagents Application Outlook (Revenue, USD Million, 2014 - 2025) PCR
Sequencing
Cloning
Epigenetics
Restriction Digestion
Synthetic Biology
Other Applications
Molecular Biology Enzymes, Kits, and Reagents Application Outlook (Revenue, USD Million, 2014 - 2025) Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Hospitals and Diagnostic Centers
Other End Users
Molecular Biology Enzymes, Kits, and Reagents Regional Outlook (Revenue, USD Million, 2014 - 2025)
Follow Us:
North America o
U.S.
o
Canada
Europe o
UK
o
Germany
o
France
Asia Pacific o
Japan
o
China
o
India
Latin America o
Brazil
MEA o
South Africa
Browse Related Category Reports @ https://www.grandviewresearch.com/industry/biotechnology Table of Content of Molecular Biology Enzymes, Kits, and Reagents Market Chapter 1 Research Methodology 1.1 Country-Wise Market: Base Estimates 1.2 Global market: CAGR calculation 1.3 Region-based Segment Share Calculation 1.4 Research Scope & Assumptions 1.5 List of Data Sources 1.5.1 Data for primary interviews, by sources 1.5.2 Data for primary interviews, by region Chapter 2 Executive Summary 2.1 Market Snapshot Chapter 3 Molecular Biology Enzymes Kits & Reagents Market Variables, Trends & Scope 3.1 Market Segmentation & Scope 3.2 Market Driver Analysis 3.2.1 Technological advancements 3.2.2 Increasing research activities among the end users 3.2.3 Rising incidence of diseases and genetic disorders 3.3 Market Restraint Analysis 3.3.1 Genetic information privacy
Follow Us:
3.3.2 Lack of Reimbursement for Genetic Testing in selected countries 3.5 Molecular biology enzymes, kits, and reagents - SWOT Analysis, by Factor (Political & Legal, Economic, and Technological) 3.6 Industry Analysis - Porter’s Chapter 4 Molecular Biology Enzymes Kits & Reagents: Product Estimates & Trend Analysis 4.1 Molecular Biology Enzymes, Kits, And Reagents Market: Product Movement Analysis 4.2 Kits & Reagents 4.2.1 Kits and reagents market estimates and forecasts, 2014 - 2025 (USD Million) 4.3 Enzymes 4.3.1 Enzymes market estimates and forecasts, 2014 - 2025 (USD Million) Chapter 5 Molecular Biology Enzymes Kits & Reagents: Application Estimates & Trend Analysis 5.1 Molecular Biology Enzymes, Kits, and Reagents Market: Application Movement Analysis 5.2 Polymerase Chain Reaction (PCR) 5.2.1 PCR market estimates and forecasts, 2014 - 2025 (USD Million) 5.3 Sequencing 5.3.1 Sequencing market estimates and forecasts, 2014 - 2025 (USD Million) 5.4 Restriction Digestion 5.4.1 Restriction digestion market estimates and forecasts, 2014 - 2025 (USD Million) 5.5 Cloning 5.5.1 Cloning market estimates and forecasts, 2014 - 2025 (USD Million) 5.6 Epigenetics 5.6.1 Epigenetics market estimates and forecasts, 2014 - 2025 (USD Million) 5.7 Synthetic Biology 5.7.1 Synthetic biology market estimates and forecasts, 2014 - 2025 (USD Million) 5.8 Others 5.8.1 Others market estimates and forecasts, 2014 - 2025 (USD Million) Chapter 6 Molecular Biology Enzymes Kits & Reagents: End User Estimates & Trend Analysis 6.1 Molecular Biology Enzymes, Kits, and Reagents Market: Application Movement Analysis 6.2 Academic and Research Institutes 6.2.1 Academic and research institutes market estimates and forecasts, 2014 - 2025 (USD Million) 6.3 Hospitals and Diagnostic Centers 6.3.1 Hospitals and diagnostic centres market estimates and forecasts, 2014 - 2025 (USD Million) 6.4 Pharmaceutical and Biotechnology Companies 6.4.1 Pharmaceutical and biotechnology companies market estimates and forecasts, 2014 - 2025 (USD Million) 6.5 Others 6.5.1 Other end users market estimates and forecasts, 2014 - 2025 (USD Million) Chapter 7 Molecular Biology Enzymes, Kits, & Reagents: Regional Estimates & Trend Analysis, by Product, Application, & End User 7.1 Molecular Biology Enzymes, Kits, and Regents Market Share By Region, 2016 & 2025 7.2 North America 7.2.1 Market estimates and forecasts by product, 2014 - 2025 (USD Million)
Follow Us:
7.2.2 Market estimates and forecasts by application, 2014 - 2025 (USD Million) 7.2.3 Market estimates and forecasts by end user, 2014 - 2025 (USD Million) 7.2.4 U.S. 7.2.4.1 Increasing research in the genomics application area 7.2.4.2 Rising pharmaceutical industry in U.S. to augment the market growth 7.2.4.4 Market estimates and forecasts by product, 2014 - 2025 (USD Million) 7.2.4.5 Market estimates and forecasts by application, 2014 - 2025 (USD Million) 7.2.4.6 Market estimates and forecasts by end user, 2014 - 2025 (USD Million) 7.2.5 Canada 7.2.5.1 Market estimates and forecasts by product, 2014 - 2025 (USD Million) 7.2.5.2 Market estimates and forecasts by application, 2014 - 2025 (USD Million) 7.2.5.3 Market estimates and forecasts by end user, 2014 - 2025 (USD Million) 7.3 Europe 7.3.1 Market estimates and forecasts by product, 2014 - 2025 (USD Million) 7.3.2 Market estimates and forecasts by application, 2014 - 2025 (USD Million) 7.3.3 Market estimates and forecasts by end user, 2014 - 2025 (USD Million) 7.3.4 UK 7.3.4.1 Market estimates and forecasts by product, 2014 - 2025 (USD Million) 7.3.4.2 Market estimates and forecasts by application, 2014 - 2025 (USD Million) 7.3.4.3 Market estimates and forecasts by end user, 2014 - 2025 (USD Million) 7.3.5 Germany 7.3.5.1 Market estimates and forecasts by product, 2014 - 2025 (USD Million) 7.3.5.2 Market estimates and forecasts by application, 2014 - 2025 (USD Million) 7.3.5.3 Market estimates and forecasts by end user, 2014 - 2025 (USD Million) 7.3.6 France 7.3.6.1 Market estimates and forecasts by product, 2014 - 2025 (USD Million) 7.3.6.2 Market estimates and forecasts by application, 2014 - 2025 (USD Million) 7.3.6.3 Market estimates and forecasts by end user, 2014 - 2025 (USD Million) 7.4 Asia Pacific 7.4.1 Market estimates and forecasts by product, 2014 - 2025 (USD Million) 7.4.2 Market estimates and forecasts by application, 2014 - 2025 (USD Million) 7.4.3 Market estimates and forecasts by end user, 2014 - 2025 (USD Million) 7.4.4 Japan 7.4.4.1 Market estimates and forecasts by product, 2014 - 2025 (USD Million) 7.4.4.2 Market estimates and forecasts by application, 2014 - 2025 (USD Million) 7.4.4.3 Market estimates and forecasts by end user, 2014 - 2025 (USD Million) 7.4.5 China 7.4.5.1 Market estimates and forecasts by product, 2014 - 2025 (USD Million) 7.4.5.2 Market estimates and forecasts by application, 2014 - 2025 (USD Million) 7.4.5.3 Market estimates and forecasts by end user, 2014 - 2025 (USD Million) 7.4.6 India 7.4.6.1 Market estimates and forecasts by product, 2014 - 2025 (USD Million)
Follow Us:
7.4.6.2 Market estimates and forecasts by application, 2014 - 2025 (USD Million) 7.4.6.3 Market estimates and forecasts by end user, 2014 - 2025 (USD Million) 7.5 Latin America 7.5.1 Market estimates and forecasts by product, 2014 - 2025 (USD Million) 7.5.2 Market estimates and forecasts by application, 2014 - 2025 (USD Million) 7.5.3 Market estimates and forecasts by end user, 2014 - 2025 (USD Million) 7.5.4 Brazil 7.5.4.1 Market estimates and forecasts by product, 2014 - 2025 (USD Million) 7.5.4.2 Market estimates and forecasts by application, 2014 - 2025 (USD Million) 7.5.4.3 Market estimates and forecasts by end user, 2014 - 2025 (USD Million) 7.6 MEA 7.6.1 Market estimates and forecasts by product, 2014 - 2025 (USD Million) 7.6.2 Market estimates and forecasts by application, 2014 - 2025 (USD Million) 7.6.3 Market estimates and forecasts by end user, 2014 - 2025 (USD Million) 7.6.4 South Africa 7.6.4.1 Market estimates and forecasts by product, 2014 - 2025 (USD Million) 7.6.4.2 Market estimates and forecasts by application, 2014 - 2025 (USD Million) 7.6.4.3 Market estimates and forecasts by end user, 2014 - 2025 (USD Million) Chapter 8 Competitive Landscape 8.1 Strategy framework 8.2 Company Profiles 8.2.1 New England Biolabs Inc 8.2.1.1 Company Overview 8.2.1.2 Product benchmarking 8.2.1.3 Strategic initiatives 8.2.2 Illumina Inc. 8.2.2.1 Company Overview 8.2.2.2 Financial Performance 8.2.2.3 Product benchmarking 8.2.2.4 Strategic initiatives 8.2.3 Qiagen N.V. 8.2.3.1 Company overview 8.2.3.2 Financial performance 8.2.3.3 Product benchmarking 8.2.3.4 Strategic initiatives 8.2.4 Takara Bio, Inc. 8.2.4.1 Company overview 8.2.4.2 Financial performance 8.2.4.3 Product benchmarking 8.2.4.4 Strategic initiatives 8.2.5 Agilent Technologies 8.2.5.1 Company overview
Follow Us:
8.2.5.2 Financial performance 8.2.5.3 Product benchmarking 8.2.5.4 Strategic initiatives 8.2.6 Promega Corporation 8.2.6.1 Company overview 8.2.6.2 Product benchmarking 8.2.6.3 Strategic initiatives 8.2.7 Thermo Fisher Scientific Inc. 8.2.7.1 Company overview 8.2.7.2 Financial performance 8.2.7.3 Product benchmarking 8.2.7.4 Strategic initiatives 8.2.8 Lucigen Corporation 8.2.8.1 Company overview 8.2.8.2 Product benchmarking 8.2.8.3 Strategic initiatives 8.2.9 Merck KGaA 8.2.9.1 Company overview 8.2.9.2 Financial performance 8.2.9.3 Product benchmarking 8.2.9.4 Strategic initiatives 8.2.10 F. Hoffmann-La Roche Ltd. 8.2.10.1 Company overview 8.2.10.2 Financial performance 8.2.10.3 Product benchmarking
About Us: Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Follow Us:
Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email: sales@grandviewresearch.com For More Information: http://www.grandviewresearch.com
Follow Us: